Anti-Brexit campaign group Best for Britain has cautioned that the UK Government’s plan for stockpiling six week’s worth of medicines in case of a no-deal Brexit could cost up to £2bn. Credit: Shutterstock.

Anti-Brexit campaign group Best for Britain has cautioned that the UK Secretary of State for Health and Social Care Matt Hancock’s plan for six weeks of medicines to be stockpiled in the event of a no-deal Brexit could cost up to £2bn.

It is currently unclear who would be responsible for this bill.

This price of stockpiling medicines for a no-deal Brexit is based upon data from a report published by healthcare think tank King’s Fund in April this year, which estimated that the total spent by the NHS on medicines in 2016-17 was $17.4bn.

Best for Britain supporter and Labour MP Owen Smith said: “I don’t remember anyone warning that Brexit would mean we’d have stockpile drugs or this would cost the NHS and taxpayers up to £2bn. Maybe they should have slapped that on the side of the bus. Every day it seems as though there is another hidden cost being revealed.”

Hancock announced the government’s strategy for stockpiling medicines for a no-deal Brexit in a letter addressed to pharmaceutical companies. As well as calling on them to increase their stock of medicines by at least six weeks on top of their existing buffer stocks, the companies were asked to ensure they had plans to air freight products with a short shelf life into the UK.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Health Secretary also sent a letter to NHS organisations in which he urged GPs, pharmacists and other healthcare professionals to not start stockpiling medicines for a no-deal Brexit and instead rely on pharmaceutical companies.

Hancock wrote: “Local stockpiling is not necessary and any incidences involving the over ordering of medicines will be investigated and followed up with the relevant Chief or Responsible Pharmacist directly.

“Clinicians should advise patients that the government has plans in place to ensure a continued supply of medicines to patients from the moment we leave the EU. Patients will not need to and should not seek to store additional medicines at home.”